Mark R. Kelley is the newest member of the IU Ventures Investment Committee. Kelley, a professor of pediatrics and cancer researcher at Indiana University School of Medicine, was appointed by Jay L. Hess, dean of IU School of Medicine and an IU Ventures board member. Kelley succeeds Distinguished Professor Emeritus Mervin Yoder, who served on the committee from 2014 to 2020.
IU Ventures focuses on nurturing an entrepreneurial ecosystem within the IU community through robust resources, funding opportunities and events. Central to this mission, the investment committee’s role is to assess investment opportunities from IU-affiliated entrepreneurs and advise IU Ventures in its decision-making process.
Kelley himself is an IU entrepreneur, serving as the chief scientific officer of Apexian Pharmaceuticals. His expertise has led to the intellectual property rights on 12 published patents, with 16 more pending. Read more on the IU School of Medicine newsroom.